UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Targeting protein-tyrosine phosphatases in breast cancer

Oncotarget, 2012-05, Vol.3 (5), p.514-515

2012

Link zum Volltext

Verfügbarkeit prüfen

Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages

Oncotarget, 2016-12, Vol.7 (50), p.82289-82304

2016

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

Oncotarget, 2015-03, Vol.6 (8), p.6191-6202

2015

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue

Oncotarget, 2017-04, Vol.8 (14), p.22353-22360

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Oncotarget, 2016-05, Vol.7 (19), p.28697-28710

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome

Oncotarget, 2016-04, Vol.7 (16), p.21922-21938

2016

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid metabolism in breast cancer subtypes

Oncotarget, 2017-04, Vol.8 (17), p.29487-29500

Monaco, Marie E

2017

Link zum Volltext

Verfügbarkeit prüfen

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Oncotarget, 2015-09, Vol.6 (28), p.26483-26493

2015

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors

Oncotarget, 2016-02, Vol.7 (8), p.9250-9270

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment

Oncotarget, 2016-08, Vol.7 (31), p.49349-49367

2016

Link zum Volltext

Verfügbarkeit prüfen

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Oncotarget, 2016-01, Vol.7 (4), p.4428-4441

2016

Link zum Volltext

Verfügbarkeit prüfen

Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI

Oncotarget, 2017-07, Vol.8 (28), p.45759-45767

2017

Link zum Volltext

Verfügbarkeit prüfen

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling

Oncotarget, 2017-01, Vol.8 (4), p.5976-5991

2017

Link zum Volltext

Verfügbarkeit prüfen

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling

Oncotarget, 2015-05, Vol.6 (13), p.11585-11599

2015

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer

Oncotarget, 2015-06, Vol.6 (17), p.14913-14925

2015

Link zum Volltext

Verfügbarkeit prüfen

Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy

Oncotarget, 2017-12, Vol.8 (64), p.107374-107389

2017

Link zum Volltext

Verfügbarkeit prüfen

SHP2 phosphatase as a novel therapeutic target for melanoma treatment

Oncotarget, 2016-11, Vol.7 (45), p.73817-73829

2016

Link zum Volltext

Verfügbarkeit prüfen

CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway

Oncotarget, 2016-03, Vol.7 (13), p.15632-15647

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

Oncotarget, 2017-06, Vol.8 (24), p.39230-39240

2017

Link zum Volltext

Verfügbarkeit prüfen

IκBζ: an emerging player in cancer

Oncotarget, 2016-10, Vol.7 (40), p.66310-66322

2016

Link zum Volltext

Verfügbarkeit prüfen

Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker

Oncotarget, 2017-09, Vol.8 (43), p.75742-75755

2017

Link zum Volltext

Verfügbarkeit prüfen

SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells

Oncotarget, 2017-08, Vol.8 (32), p.53518-53530

2017

Link zum Volltext

Verfügbarkeit prüfen

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer

Oncotarget, 2017-12, Vol.8 (70), p.115270-115279

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic siRNA for drug-resistant HER2-positive breast cancer

Oncotarget, 2016-03, Vol.7 (12), p.14727-14741

2016

Link zum Volltext

Verfügbarkeit prüfen

Shp2 regulates migratory behavior and response to EGFR-TKIs through ERK1/2 pathway activation in non-small cell lung cancer cells

Oncotarget, 2017-10, Vol.8 (53), p.91123-91133

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Zeitschrift / SerieOncotarget

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(60)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Cell Biology
(60)
Oncology
(60)
Science & Technology
(60)
Research Paper
(48)
Humans
(43)
Female
(30)
Animals
(27)
Mice
(21)
Cell Line, Tumor
(20)
Breast Cancer
(17)
Breast Neoplasms - Pathology
(14)
Signal Transduction
(12)
Gene Expression Regulation, Neoplastic
(10)
Breast Neoplasms - Metabolism
(9)
Male
(9)
Mice, Nude
(9)
Rna Interference
(9)
Breast Neoplasms - Drug Therapy
(8)
Cell Proliferation - Drug Effects
(8)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(60)
MEDLINE
(47)

Menü

Weitere Dienste

Einstellungen

Targeting protein-tyrosine phosphatases in breast cancer

Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages

Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma

Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome

Fatty acid metabolism in breast cancer subtypes

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors

Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI

STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling

Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer

Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy

SHP2 phosphatase as a novel therapeutic target for melanoma treatment

CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway

Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

IκBζ: an emerging player in cancer

Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker

SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer

Therapeutic siRNA for drug-resistant HER2-positive breast cancer

Shp2 regulates migratory behavior and response to EGFR-TKIs through ERK1/2 pathway activation in non-small cell lung cancer cells

Aktive Filter

Suchergebnisse filtern